- Advertisement -spot_img
Thursday, February 29, 2024

Top 10 Nephrology Solution Providers 2022

Nephrology is the branch of internal medicine’s subspecialty that deals with the diagnosis and treatment of kidney-related diseases.  Amidst the rising tide of chronic kidney disease (CKD) burden, the global nephrology workforce has failed to expand in order to meet the growing healthcare needs of this vulnerable patient population. Amidst the rising tide of CKD, the global nephrology workforce has shrunk and is failing to meet the growing healthcare needs of this vulnerable patient population. In truth, this global shortage of nephrologists is seen in many parts of the world. Several kidney complications are systematic disorders, i.e., they are not only confined to the organ itself. These conditions need specialized treatment and medical care.

The global dialysis population is growing rapidly, especially in low-income and middle-income countries; however, worldwide, a substantial number of people lack access to kidney replacement therapy, and millions of people die of kidney failure each year, often without supportive care. The costs of dialysis care are high and will likely continue to rise as a result of increased life expectancy and improved therapies for causes of kidney failure such as diabetes mellitus and cardiovascular disease. Patients, payors, regulators, and health-care systems increasingly demand improved value in dialysis care, which can only come about through true patient-centered innovation that supports high-quality, high-value care.

With so many trends swirling around the healthcare diagnostics space, healthcare facilities and practitioners are having a difficult time locating the right solution provider who precisely fits the unique and changing customer requirements. To help our readers and your prospective clients get a clearer picture of the industry, our panel  of CEOs, CTOs, and healthcare specialists has developed a list of companies. Listed below are the “Top 10 Nephrology Solution Providers 2022,” who are creating a difference in the industry with their innovative solutions.

Conifer Health Solutions

Management:

Roger Davis

Designation:

President & CEO

Headquarters:

Frisco, TX

Website:

coniferhealth.com

Conifer Health Solutions is a healthcare services company helping organizations strengthen their financial performance, the transition from volume to value-based care, and enhance the consumer and patient healthcare experience—ultimately improving the quality, cost, and access to healthcare.

Evergreen Nephrology

Management:

Adam Boehler

Designation:

Co-Founder

Headquarters:

Nashville, TN

Website:

evergreennephrology.com

Evergreen helps nephrologists focus on the right patients across the full care spectrum at the right time. They create strategic partnerships to empower nephrologists with financial backing. As part of that partnership, we provide nephrologists with the best-in-class interdisciplinary clinical resources, analytical insight and tools, and services to patients.

Fresenius Medical Care

Management:

Dr. Carla Kriwet

Designation:

CEO & Chair

Headquarters:

Bad Homburg, Germany

Website:

freseniusmedicalcare.com

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa.

Goldfinch Bio

Management:

Anthony Johnson

Designation:

President & CEO

Headquarters:

Cambridge, MA

Website:

goldfinchbio.com

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease.

hemotune

Management:

Lukas Langenegger

Designation:

CEO

Headquarters:

Zurich, Switzerland

Website:

hemotune.ch

Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments.

Invizius

Management:

Richard Boyd

Designation:

CEO

Headquarters:

Edinburgh, UK

Website:

invizius.com

Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.

NephroSant

Management:

Dr. Minnie Sarwal

Designation:

Co-Founder & CEO

Headquarters:

Brisbane, CA

Website:

nephrosant.com

NephroSant is a biotechnology company that develops pioneering diagnostic tools for the early detection of the risk of kidney disease or injury and long-term monitoring of kidney health. NephroSant is a diagnostic platform company dedicated to understanding the spectrum of kidney health.

pulseData

Management:

Hai Po Sun

Designation:

Co-Founder & CTO

Headquarters:

New York, NY

Website:

pulsedata.io

We deliver deep intelligence on individuals, and context on their condition; details often undiagnosed or missed. As our partners attain a clear and continuous diagnosis of individuals, they are armed with proactive paths to improve lives and outcomes. We deliver data and insights in ample time; engineered to avoid tragic, preventable, and costly events at scale.

Strive Health

Management:

Chris Riopelle

Designation:

CEO

Headquarters:

Denver, CO

Website:

strivehealth.com

Strive Health is a built-for-purpose company working with innovative payors and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-level engagement through dialysis.

Vifor Pharma Management

Management:

Florian Jehle

Designation:

CEO

Headquarters:

Glattbrugg, Zurich

Website:

viforpharma.com

Vifor Pharma Group, formerly Galenica Group, is a global pharmaceutical company that researches, develops, produces, and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions. The company’s goal is to be a global leader in iron deficiency, nephrology, and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.

Translate »